Impact of Amending the Acetylcysteine Marketing Authorisation on Treatment of Paracetamol Overdose

ISRN Toxicology
doi 10.1155/2013/494357
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Efficacy of a Two Bag Acetylcysteine Regimen to Treat Paracetamol Overdose (2NAC Study)

EClinicalMedicine
Medicine
2020English

Paracetamol Overdose: A Plan of Management

Anaesthesia and Intensive Care
Critical CareAnesthesiologyPain MedicineIntensive Care Medicine
1974English

Activated Charcoal in Paracetamol Overdose

Emergency Medicine Journal
MedicineCritical CareEmergency MedicineIntensive Care Medicine
2000English

Acute Liver Necrosis Following Overdose of Paracetamol.

BMJ
1966English

Target Biomarker Profile for the Clinical Management of Paracetamol Overdose

British Journal of Clinical Pharmacology
Pharmacology
2015English

Oral or Intravenous Antidote for Paracetamol Overdose

Emergency Medicine Journal
MedicineCritical CareEmergency MedicineIntensive Care Medicine
2002English

Cysteamine or N-Acetylcysteine for Paracetamol Poisoning?

BMJ
1978English

Php359 - Impact of Expedited Marketing Authorisation on Pricing and Reimbursement Outcomes for Drugs in the Us and Eu-5

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Effectiveness of Delayed Activated Charcoal Administration in Simulated Paracetamol (Acetaminophen) Overdose

British Journal of Clinical Pharmacology
Pharmacology
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy